Mengzhong Liu
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Otorhinolaryngology top 0.5%
- Molecular Biology
- Topics
- Esophageal Cancer Research and Treatment (33 papers)Gastric Cancer Management and Outcomes (19 papers)Esophageal and GI Pathology (15 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Mengzhong Liu
73 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Surgery 896
- Pulmonary and Respiratory Medicine 803
- Oncology 749
- Otorhinolaryngology 674
- Molecular Biology 431
Countries citing papers authored by Mengzhong Liu
This map shows the geographic impact of Mengzhong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengzhong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengzhong Liu more than expected).
Fields of papers citing papers by Mengzhong Liu
This network shows the impact of papers produced by Mengzhong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengzhong Liu. The network helps show where Mengzhong Liu may publish in the future.
Co-authorship network of co-authors of Mengzhong Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Mengzhong Liu. A scholar is included among the top collaborators of Mengzhong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengzhong Liu. Mengzhong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 4 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 23 | |
| 7 | 17 | |
| 8 | 2 | |
| 9 | 0 | |
| 10 | 62 | |
| 11 | 16 | |
| 12 | 2 | |
| 13 | 24 | |
| 14 | 17 | |
| 15 | 17 | |
| 16 | 27 | |
| 17 | 1 | |
| 18 | 1 | |
| 19 | 98 | |
| 20 | A prospective randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma | 1 |
About Mengzhong Liu
Mengzhong Liu is a scholar working on Otorhinolaryngology, Hepatology and Pulmonary and Respiratory Medicine, having authored 77 papers that have together received 1.9k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (33 papers), Gastric Cancer Management and Outcomes (19 papers) and Esophageal and GI Pathology (15 papers). The work is most often cited by research in Otorhinolaryngology (674 citations), Oncology (749 citations) and Pulmonary and Respiratory Medicine (803 citations). Mengzhong Liu has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Ying Sun, Aihua Lin, Jun Ma, Lizhi Liu, Lei Chen, Wei Luo, Wen‐Fei Li, Yuanyuan Chen, Mian Xi and Shiliang Liu. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.